Published in Intern Emerg Med on September 18, 2010
Predictors of Mortality in Paediatric Myocarditis. J Clin Diagn Res (2016) 1.09
Clinical relevance of biomarkers in heart failure and cardiorenal syndrome: the role of natriuretic peptides and troponin. Heart Fail Rev (2014) 0.87
Hyperthermia by bathing in a hot spring improves cardiovascular functions and reduces the production of inflammatory cytokines in patients with chronic heart failure. Heart Vessels (2012) 0.84
Natriuretic peptides in heart failure: where we are, where we are going. Intern Emerg Med (2011) 0.79
Relative Change in NT-proBNP Level: An Important Risk Predictor of Cardiovascular Congestion in Haemodialysis Patients. Nephron Extra (2012) 0.77
The usefulness of brain natriuretic peptide level in diagnosis and prognosis of patients admitted to critical care unit with shortness of breath. J Emerg Trauma Shock (2015) 0.75
Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial. J Bone Miner Res (2013) 1.68
Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome. Am Heart J (2007) 1.67
Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis: bone density, mass, and strength of the radius, and wrist fracture. Menopause (2013) 1.47
Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men. J Clin Endocrinol Metab (2003) 1.47
Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes. J Clin Endocrinol Metab (2012) 1.27
Genome-wide association identifies three new susceptibility loci for Paget's disease of bone. Nat Genet (2011) 1.20
Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia. Am Heart J (2006) 1.15
Fracture incidence and characterization in patients on osteoporosis treatment: the ICARO study. J Bone Miner Res (2006) 1.13
Osteoporosis and risk of fracture in patients with diabetes: an update. Aging Clin Exp Res (2011) 1.09
Aromatase activity and bone homeostasis in men. J Clin Endocrinol Metab (2004) 1.08
FSHR gene polymorphisms influence bone mineral density and bone turnover in postmenopausal women. Eur J Endocrinol (2010) 1.05
SQSTM1 gene analysis and gene-environment interaction in Paget's disease of bone. J Bone Miner Res (2010) 1.04
Circumferential versus longitudinal systolic function in patients with hypertension: a nonlinear relation. J Am Soc Echocardiogr (2007) 1.03
Endocrine actions of osteocalcin. Int J Endocrinol (2013) 1.02
Prospective study of sexual dysfunction in men with rectal cancer: feasibility and results of nerve sparing surgery. Int J Colorectal Dis (2010) 1.01
The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels. Thyroid (2008) 1.01
Prevalence of Paget's disease of bone in Italy. J Bone Miner Res (2005) 0.99
Selective estrogen receptor modulators for postmenopausal osteoporosis: current state of development. Drugs Aging (2007) 0.97
The TARGET project in Tuscany: the first disease management model of a regional project for the prevention of hip re-fractures in the elderly. Clin Cases Miner Bone Metab (2010) 0.93
Physical activity and bone turnover markers: a cross-sectional and a longitudinal study. Calcif Tissue Int (2008) 0.93
Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone. J Bone Miner Res (2007) 0.93
Relation of plasma brain natriuretic peptide levels in non-ST-elevation coronary disease and preserved systolic function to number of narrowed coronary arteries. Am J Cardiol (2005) 0.92
Hypertension, left ventricular hypertrophy and chronic kidney disease. Heart Fail Rev (2011) 0.91
Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial. Crit Care (2014) 0.91
Characteristics and familial aggregation of Paget's disease of bone in Italy. J Bone Miner Res (2005) 0.89
Evidence for increased clinical severity of familial and sporadic Paget's disease of bone in Campania, southern Italy. J Bone Miner Res (2006) 0.88
Paget's disease of bone in Italy. J Bone Miner Res (2006) 0.88
Clinical characteristics and evolution of giant cell tumor occurring in Paget's disease of bone. J Bone Miner Res (2015) 0.88
Prevalence of risk factors, coronary and systemic atherosclerosis in abdominal aortic aneurysm: comparison with high cardiovascular risk population. Vasc Health Risk Manag (2008) 0.88
Quantitative ultrasound and dual-energy X-ray absorptiometry in the prediction of fragility fracture in men. Osteoporos Int (2004) 0.87
Admission plasma neutrophil gelatinase associated lipocalin (NGAL) predicts worsening renal function during hospitalization and post discharge outcome in patients with acute heart failure. Acute Card Care (2014) 0.87
Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene. Clin Interv Aging (2010) 0.87
Bazedoxifene for the prevention of postmenopausal osteoporosis. Ther Clin Risk Manag (2008) 0.87
Brain natriuretic peptide and other risk markers for outcome assessment in patients with non-ST-elevation coronary syndromes and preserved systolic function. Am J Cardiol (2006) 0.87
Cross-sectional study: CagA-positive Helicobacter pylori infection, acute coronary artery disease and systemic levels of B-type natriuretic peptide. J Clin Pathol (2013) 0.86
A nonsynonymous TNFRSF11A variation increases NFκB activity and the severity of Paget's disease. J Bone Miner Res (2012) 0.85
Pharmacological treatment of hip fractured patients in Italy: a simulation based on Tuscany regional database for the TARGET project. Clin Cases Miner Bone Metab (2010) 0.85
Expanding the phenotype of 22q11 deletion syndrome: the MURCS association. Clin Dysmorphol (2008) 0.84
Beyond glycemic control in diabetes mellitus: effects of incretin-based therapies on bone metabolism. Front Endocrinol (Lausanne) (2013) 0.83
The relationship between plasma homocysteine levels and bone mineral density in post-menopausal women. Eur J Intern Med (2010) 0.83
Raloxifene in breast cancer prevention. Expert Opin Drug Saf (2008) 0.83
Immune and autoimmune disorders in HCV chronic liver disease: personal experience and commentary on literature. New Microbiol (2005) 0.83
Helicobacter pylori immunoproteomes in case reports of rosacea and chronic urticaria. Proteomics (2005) 0.83
The prevention of fragility fractures in diabetic patients. Aging Clin Exp Res (2014) 0.83
Anemia in Cardio-Renal Syndrome: clinical impact and pathophysiologic mechanisms. Heart Fail Rev (2011) 0.82
Dual X-ray and laser absorptiometry of the calcaneus: comparison with quantitative ultrasound and dual-energy X-ray absorptiometry. J Clin Densitom (2004) 0.81
Steroid hormone receptor gene polymorphisms and osteoporosis: a pharmacogenomic review. Expert Opin Pharmacother (2007) 0.81
Possible pathogenetic role of antiphospholipid antibodies in a clinical case of human immunodeficiency virus infection with peripheral polyneuropathy and arterial thrombosis. New Microbiol (2005) 0.81
Giant cell tumor occurring in familial Paget's disease of bone: report of clinical characteristics and linkage analysis of a large pedigree. J Bone Miner Res (2013) 0.81
Lasofoxifene: a third-generation selective estrogen receptor modulator for the prevention and treatment of osteoporosis. Expert Opin Investig Drugs (2006) 0.80
B-type natriuretic peptide as an independent predictor of coronary disease extension in non-ST elevation coronary syndromes with preserved systolic function. Eur J Prev Cardiol (2011) 0.80
The effects of zoledronic acid on serum lipids in multiple myeloma patients. Calcif Tissue Int (2008) 0.80
Left ventricular twisting modifications in patients with left ventricular concentric hypertrophy at increasing after-load conditions. Echocardiography (2014) 0.80
The associations of body composition and fat distribution with bone mineral density in elderly Italian men and women. J Clin Densitom (2012) 0.80
Ospemifene use in postmenopausal women. Expert Opin Investig Drugs (2009) 0.80
Left ventricular remodelling and systolic function measurement with 64 multi-slice computed tomography versus second harmonic echocardiography in patients with coronary artery disease: a double blind study. Eur J Radiol (2008) 0.80
Detection of early left ventricular and atrial dysfunction in overweight patients with preserved ejection fraction: a speckle tracking analysis. Echocardiography (2013) 0.80
Left ventricular twisting as determinant of diastolic function: a speckle tracking study in patients with cardiac hypertrophy. Echocardiography (2011) 0.80
Paraneoplastic necrotizing myopathy associated with adenocarcinoma of the lung - a rare entity with atypical onset: a case report. J Med Case Rep (2013) 0.80
Anemia correction by erythropoietin reduces BNP levels, hospitalization rate, and NYHA class in patients with cardio-renal anemia syndrome. Clin Exp Med (2010) 0.80
The effect of zoledronic acid on serum osteoprotegerin in early stage multiple myeloma. Haematologica (2006) 0.79
Influence of Helicobacter pylori infection on metabolic parameters and body composition of dyslipidemic patients. Intern Emerg Med (2014) 0.79
Beta-erythropoietin effects on ventricular remodeling, left and right systolic function, pulmonary pressure, and hospitalizations in patients affected with heart failure and anemia. J Cardiovasc Pharmacol (2009) 0.79
The impact of infarct size on regional and global left ventricular systolic function: a cardiac magnetic resonance imaging study. Int J Cardiovasc Imaging (2015) 0.78
Quantitative ultrasound and dual-energy x-ray absorptiometry in children and adolescents with neurofibromatosis of type 1. J Clin Densitom (2010) 0.78
Lasofoxifene: Evidence of its therapeutic value in osteoporosis. Core Evid (2010) 0.78
Update on the pharmacogenetics of the vitamin D receptor and osteoporosis. Pharmacogenomics (2009) 0.78
Natriuretic peptides and NGAL in heart failure: does a link exist? Clin Chim Acta (2012) 0.78
B-type natriuretic peptide levels predict extent and severity of coronary disease in non-ST elevation coronary syndromes and normal left ventricular systolic function. Regul Pept (2011) 0.78
Brain natriuretic peptide levels during cardiac reperfusion: comparison between percutaneous coronary angioplasty and aorto-coronaric bypass. Clin Chim Acta (2004) 0.78
The burden of previous fractures in hip fracture patients. The Break Study. Aging Clin Exp Res (2011) 0.78
Proteomics of human primary osteoarthritic chondrocytes exposed to extremely low-frequency electromagnetic fields (ELF EMFs) and to therapeutic application of musically modulated electromagnetic fields (TAMMEF). Electromagn Biol Med (2013) 0.77
Serum relaxin in systemic sclerosis. J Rheumatol (2005) 0.77
Osteoprotegerin and B-type natriuretic peptide in non-ST elevation acute coronary syndromes: relation to coronary artery narrowing and plaques number. Clin Chim Acta (2008) 0.77
Vitamin D receptor gene polymorphisms predict acquired resistance to clodronate treatment in patients with Paget's disease of bone. Calcif Tissue Int (2008) 0.77
Heart failure: pathophysiology and clinical picture. Contrib Nephrol (2010) 0.77
Aromatase activity and bone loss in men. J Osteoporos (2011) 0.77
Left ventricular diastolic function improvement by carvedilol therapy in advanced heart failure. J Cardiovasc Pharmacol (2005) 0.77
Lasofoxifene, from the preclinical drug discovery to the treatment of postmenopausal osteoporosis. Expert Opin Drug Discov (2011) 0.77
Human osteoarthritic chondrocytes exposed to extremely low-frequency electromagnetic fields (ELF) and therapeutic application of musically modulated electromagnetic fields (TAMMEF) systems: a comparative study. Rheumatol Int (2012) 0.77
Aromatase activity and bone loss. Adv Clin Chem (2011) 0.76
H pylori infection and systemic antibodies to CagA and heat shock protein 60 in patients with coronary heart disease. World J Gastroenterol (2006) 0.76
Comparison of intravenous and intramuscular neridronate regimens for the treatment of Paget disease of bone. J Bone Miner Res (2011) 0.76
Long-term bone density evaluation in cerebrotendinous xanthomatosis: evidence of improvement after chenodeoxycholic acid treatment. Calcif Tissue Int (2012) 0.76
Kidney disease in heart failure: the importance of novel biomarkers for type 1 cardio-renal syndrome detection. Intern Emerg Med (2015) 0.76
Short and long-term effects of continuous versus intermittent loop diuretics treatment in acute heart failure with renal dysfunction. Intern Emerg Med (2014) 0.76
Pharmacokinetic evaluation of toremifene and its clinical implications for the treatment of osteoporosis. Expert Opin Drug Metab Toxicol (2012) 0.76
The E/e' ratio in the gray zone as predictor of left atrial dysfunction in patients with normal left ventricular ejection fraction: a speckle tracking study. Int J Cardiol (2012) 0.75